These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 38442715)

  • 1. Untargeted metabolomics reveals potential plasma biomarkers for diagnosis of primary aldosteronism using liquid chromatography-mass spectrometry.
    Song JJ; Cai J; Ma WJ; Lou Y; Bian J; Zhao B; She X; Liu XN
    Biomed Chromatogr; 2024 Jun; 38(6):e5855. PubMed ID: 38442715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A LC-MS/MS method for the simultaneous quantitative determination of aldosterone, its precursor 18-hydroxycorticosterone and its metabolite tetrahydroaldosterone in human urine.
    Dong H; Hu B; Chen W; Wang L; Sun H; Zhou J; Chen J; Chen B; Du Z
    J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Feb; 1234():124012. PubMed ID: 38280362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Confirmatory testing of primary aldosteronism with saline infusion test and LC-MS/MS.
    Fuss CT; Brohm K; Kurlbaum M; Hannemann A; Kendl S; Fassnacht M; Deutschbein T; Hahner S; Kroiss M
    Eur J Endocrinol; 2021 Jan; 184(1):167-178. PubMed ID: 33112272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Criteria for diagnosing primary aldosteronism on the basis of liquid chromatography-tandem mass spectrometry determinations of plasma aldosterone concentration.
    Baron S; Amar L; Faucon AL; Blanchard A; Baffalie L; Faucard C; Travers S; Pagny JY; Azizi M; Houillier P
    J Hypertens; 2018 Jul; 36(7):1592-1601. PubMed ID: 29677048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of LC-MS/MS aldosterone and automated direct renin in screening for primary aldosteronism.
    Juutilainen A; Savolainen K; Romppanen J; Turpeinen U; Hämäläinen E; Kemppainen J; Moilanen L; Pulkki K
    Clin Chim Acta; 2014 Jun; 433():209-15. PubMed ID: 24661979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mass spectrometric based approaches in urine metabolomics and biomarker discovery.
    Khamis MM; Adamko DJ; El-Aneed A
    Mass Spectrom Rev; 2017 Mar; 36(2):115-134. PubMed ID: 25881008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LC-MS/MS platform-based serum untargeted screening reveals the diagnostic biomarker panel and molecular mechanism of breast cancer.
    Gong S; Wang Q; Huang J; Huang R; Chen S; Cheng X; Liu L; Dai X; Zhong Y; Fan C; Liao Z
    Methods; 2024 Feb; 222():100-111. PubMed ID: 38228196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Untargeted LC-HRMS-Based Metabolomics for Searching New Biomarkers of Pancreatic Ductal Adenocarcinoma: A Pilot Study.
    Ríos Peces S; Díaz Navarro C; Márquez López C; Caba O; Jiménez-Luna C; Melguizo C; Prados JC; Genilloud O; Vicente Pérez F; Pérez Del Palacio J
    SLAS Discov; 2017 Apr; 22(4):348-359. PubMed ID: 27655283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive metabolic profiling of Parkinson's disease by liquid chromatography-mass spectrometry.
    Shao Y; Li T; Liu Z; Wang X; Xu X; Li S; Xu G; Le W
    Mol Neurodegener; 2021 Jan; 16(1):4. PubMed ID: 33485385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated biomarker for type 2 diabetes mellitus and impaired fasting glucose based on metabolomics analysis using ultra-high performance liquid chromatography quadrupole-Orbitrap high-resolution accurate mass spectrometry.
    Long J; Liu L; Jia Q; Yang Z; Sun Z; Yan C; Yan D
    Rapid Commun Mass Spectrom; 2020 Jun; 34(12):e8779. PubMed ID: 32159245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tailored liquid chromatography-mass spectrometry analysis improves the coverage of the intracellular metabolome of HepaRG cells.
    Cuykx M; Negreira N; Beirnaert C; Van den Eede N; Rodrigues R; Vanhaecke T; Laukens K; Covaci A
    J Chromatogr A; 2017 Mar; 1487():168-178. PubMed ID: 28153450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic signatures and risk of sarcopenia in suburb-dwelling older individuals by LC-MS-based untargeted metabonomics.
    Han P; Chen X; Liang Z; Liu Y; Yu X; Song P; Zhao Y; Zhang H; Zhu S; Shi X; Guo Q
    Front Endocrinol (Lausanne); 2024; 15():1308841. PubMed ID: 38962681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liquid chromatography-mass spectrometry untargeted metabolomics reveals increased levels of tryptophan indole metabolites in urine of metabolic syndrome patients.
    Esperanza MG; Wrobel K; Ojeda AG; Garay-Sevilla ME; Escobosa ARC; Barrientos EY; Wrobel K
    Eur J Mass Spectrom (Chichester); 2020 Dec; 26(6):379-387. PubMed ID: 33295818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternate reversed-phase and hydrophilic interaction liquid chromatography coupled with mass spectrometry for broad coverage in metabolomics analysis.
    Lv W; Guo L; Zheng F; Wang Q; Wang W; Cui L; Ouyang Y; Liu X; Li E; Shi X; Xu G
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Sep; 1152():122266. PubMed ID: 32693368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aldosterone LC-MS/MS Assay-Specific Threshold Values in Screening and Confirmatory Testing for Primary Aldosteronism.
    Guo Z; Poglitsch M; McWhinney BC; Ungerer JPJ; Ahmed AH; Gordon RD; Wolley M; Stowasser M
    J Clin Endocrinol Metab; 2018 Nov; 103(11):3965-3973. PubMed ID: 30137438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The identification of novel stroke-related sphingolipid biomarkers using UPLC-MS/MS.
    Yang Z; Deng X; Zhu J; Chen S; Jiao C; Ruan Y
    Clin Chim Acta; 2024 Jan; 552():117652. PubMed ID: 37979606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of Brain Metabolites Using Two Complementary Ultrahigh-Performance Liquid Chromatography-Mass Spectrometry Methods.
    Jauregui AM; Parellada SE; Neag E; Bhattacharya SK
    Methods Mol Biol; 2023; 2571():133-142. PubMed ID: 36152157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developments in Primary Aldosteronism Subtyping Using Steroid Profiling.
    Wannachalee T; Turcu AF
    Horm Metab Res; 2020 Jun; 52(6):373-378. PubMed ID: 32330948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overcoming Sample Matrix Effect in Quantitative Blood Metabolomics Using Chemical Isotope Labeling Liquid Chromatography Mass Spectrometry.
    Chen D; Han W; Su X; Li L; Li L
    Anal Chem; 2017 Sep; 89(17):9424-9431. PubMed ID: 28787119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Untargeted Metabolomics Based on Liquid Chromatography-Mass Spectrometry for the Analysis of Plasma and Erythrocyte Samples in Childhood Obesity.
    González-Domínguez Á; Armeni M; Savolainen O; Lechuga-Sancho AM; Landberg R; González-Domínguez R
    Methods Mol Biol; 2023; 2571():115-122. PubMed ID: 36152155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.